Stem cell therapy in India is emerging as a new modality within the healthcare system. The progress is supported by numerous innovators within the country. One company forging the way is ReeLabs, a leading stem cell bank in India that is supporting the collection and storage of stem cells, as well as the development of novel stem cell therapeutics.
Diabetes Mellitus in India
According to the World Health Organization (WHO), diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Diabetes mellitus is one of the most common diseases globally.
In India, the prevalence of diabetes is rising, predominantly related to factors such as genetic factors, stress, diet, obesity, lack of meaningful exercise and lifestyle related issues. [Read more…]
ReeLabs is a leading cord blood bank in India. Cord blood banking in India is of growing importance, because the country has a population of 1.3 billion and is projected to surpass China as the world’s most populous country by 2024. India’s population growth is fueled by a birth rate (19 births/1,000 population) that substantially exceeds its death rate (7.3 deaths/1,000 population).
